investordatabase.org

InnoCom Bio Equities, Inc.

innocombio.com Direct investor

InnoCom Bio Equities manages life sciences special purpose vehicles and pursues a venture capital strategy, investing seed capital into individual first-in-class life science ventures. It also provides business support and early commercialization guidance to its portfolio companies.

InnoCom Bio Equities, Inc. is a venture capital firm. It invests directly in companies, at seed, in life sciences, biotech, human health and veterinary health.

“Sophisticated Managers of a Life Sciences Venture Capital Fund Pursuing a Venture Capital Strategy Equity & Early Commercialization for the Innovative Life Science Venture”

— InnoCom Bio Equities, Inc., own website
Layer
Direct investor
Type
Venture capital
Stage
Seed
Sectors
life sciences, biotech, human health, veterinary health, medtech, pharmaceuticals

Team, as InnoCom Bio Equities, Inc. publishes it

  • Jack E. Doty Chief Executive Officer
  • Jules D’Assonville, DVM Co-Founder
  • Joel Ehrenzweig, DVM, MRCVS Co-Founder
  • Kamlesh Doshi Managing Director for Affiliations

Names and roles exactly as listed on innocombio.com. Nothing else about these people is recorded.

Where this comes from

Every fact above was read from a page InnoCom Bio Equities, Inc. publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 16041 · added 2026-10-21 · link last verified 2026-10-21 · confidence medium

Similar investors

Listed under